Evidence map›Paper›PMID 23335493›Full record

ReviewWiley interdisciplinary reviews. Nanomedicine and nanobiotechnology

Nanomaterials and synergistic low-intensity direct current (LIDC) stimulation technology for orthopedic implantable medical devices.

Rohan A Shirwaiker, Meghan E Samberg, Paul H Cohen, Richard A Wysk, Nancy A Monteiro-Riviere

Abstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Nanotechnology in orthopedics.Journal of orthopaedics · 2017
    Review
  3. Article
  4. Article
  5. Nanomedicine applications in orthopedic medicine: state of the art.International journal of nanomedicine · 2015
    Review
  6. Antibacterial surface treatment for orthopaedic implants.International journal of molecular sciences · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Rohan A ShirwaikerFitts Department of Industrial and Systems Engineering, North Carolina State University, Raleigh, NC, USA. rashirwaiker@ncsu.edu
Meghan E Samberg
Paul H Cohen
Richard A Wysk
Nancy A Monteiro-Riviere
North Carolina State University · USUNC/NCSU Joint Department of Biomedical Engineering · US

Funding

Comparative In Vivo Biodistribution of Characterized Manufactured NanomaterialsR01ES016138 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI MONTEIRO-RIVIERE, NANCY A. · 2009 to 2010
$658k
NIEHS NIH HHS R01 ES016138
6 · The paper itself

Abstract

Nanomaterials play a significant role in biomedical research and applications because of their unique biological, mechanical, and electrical properties. In recent years, they have been utilized to improve the functionality and reliability of a wide range of implantable medical devices ranging from well-established orthopedic residual hardware devices (e.g., hip implants) that can repair defects in skeletal systems to emerging tissue engineering scaffolds that can repair or replace organ functions. This review summarizes the applications and efficacies of these nanomaterials that include synthetic or naturally occurring metals, polymers, ceramics, and composites in orthopedic implants, the largest market segment of implantable medical devices. The importance of synergistic engineering techniques that can augment or enhance the performance of nanomaterial applications in orthopedic implants is also discussed, the focus being on a low-intensity direct electric current (LIDC) stimulation technology to promote the long-term antibacterial efficacy of oligodynamic metal-based surfaces by ionization, while potentially accelerating tissue growth and osseointegration. While many nanomaterials have clearly demonstrated their ability to provide more effective implantable medical surfaces, further decisive investigations are necessary before they can translate into medically safe and commercially viable clinical applications. The article concludes with a discussion about some of the critical impending issues with the application of nanomaterials-based technologies in implantable medical devices, and potential directions to address these.

Indexed as

Equipment and SuppliesOrthopedicsProstheses and ImplantsAnimalsElectric StimulationHumansNanostructuresNanotechnology

Identifiers

PMID23335493
PMCPMC3638956
OpenAlexW1967786817

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.